English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Although the incidence of severe intraventicular hemorrhage and cystic periventricular leukomalacia in preterm infants has significantly decreased, approximately 10–15% of preterm survivors demonstrate cerebral palsy and 50–80% of extremely preterm infants demonstrate mild-to-severe neurodevelopmental impairment. Compared to term infants, preterm infants show a higher incidence of brain damage secondary to hypoxic injury, inflammation, and malnutrition. Clinical trials have evaluated outcomes following early administration of high dose erythropoietin and nutritional in terventions including early aggressive nutrition, human breast milk, and long-chain polyunsaturated fatty acids supplementation to prevent preterm infants’ neurodevelop mental impairment and improve neurodevelopmental outcome. Further stud ies are warranted to investigate the safety, optimal dose, timing, duration with respect to erythropoietin and nutritional interventions, and the optimization of a target pop ulation of preterm infants suited for interventions.

Clinical Trials for Preterm Infants' Neurodevelopment to the Norm: Erythropoietin and Nutritional Interventions